Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0030014 | CCR4-NOT complex | 3 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0140535 | intracellular protein-containing complex | 2 | 12 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A0A3Q8IJX9
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006401 | RNA catabolic process | 5 | 1 |
GO:0006402 | mRNA catabolic process | 6 | 1 |
GO:0006417 | regulation of translation | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009057 | macromolecule catabolic process | 4 | 1 |
GO:0009889 | regulation of biosynthetic process | 4 | 1 |
GO:0009890 | negative regulation of biosynthetic process | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 1 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 6 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010629 | negative regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0017148 | negative regulation of translation | 7 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0019439 | aromatic compound catabolic process | 4 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 1 |
GO:0031327 | negative regulation of cellular biosynthetic process | 6 | 1 |
GO:0034248 | regulation of amide metabolic process | 5 | 1 |
GO:0034249 | negative regulation of amide metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 1 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0046700 | heterocycle catabolic process | 4 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051246 | regulation of protein metabolic process | 5 | 1 |
GO:0051248 | negative regulation of protein metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
GO:2000112 | obsolete regulation of cellular macromolecule biosynthetic process | 6 | 1 |
GO:2000113 | obsolete negative regulation of cellular macromolecule biosynthetic process | 7 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.617 |
CLV_NRD_NRD_1 | 139 | 141 | PF00675 | 0.765 |
CLV_NRD_NRD_1 | 294 | 296 | PF00675 | 0.652 |
CLV_NRD_NRD_1 | 298 | 300 | PF00675 | 0.693 |
CLV_NRD_NRD_1 | 401 | 403 | PF00675 | 0.565 |
CLV_NRD_NRD_1 | 453 | 455 | PF00675 | 0.581 |
CLV_NRD_NRD_1 | 505 | 507 | PF00675 | 0.669 |
CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.617 |
CLV_PCSK_KEX2_1 | 298 | 300 | PF00082 | 0.653 |
CLV_PCSK_KEX2_1 | 401 | 403 | PF00082 | 0.641 |
CLV_PCSK_KEX2_1 | 453 | 455 | PF00082 | 0.581 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.495 |
CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.566 |
CLV_PCSK_SKI1_1 | 140 | 144 | PF00082 | 0.610 |
CLV_PCSK_SKI1_1 | 348 | 352 | PF00082 | 0.694 |
CLV_PCSK_SKI1_1 | 447 | 451 | PF00082 | 0.530 |
DEG_APCC_DBOX_1 | 453 | 461 | PF00400 | 0.577 |
DEG_SPOP_SBC_1 | 158 | 162 | PF00917 | 0.486 |
DOC_ANK_TNKS_1 | 61 | 68 | PF00023 | 0.740 |
DOC_CDC14_PxL_1 | 166 | 174 | PF14671 | 0.673 |
DOC_MAPK_gen_1 | 474 | 482 | PF00069 | 0.640 |
DOC_MAPK_MEF2A_6 | 476 | 484 | PF00069 | 0.526 |
DOC_PP1_RVXF_1 | 550 | 556 | PF00149 | 0.591 |
DOC_PP2B_LxvP_1 | 365 | 368 | PF13499 | 0.513 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.546 |
DOC_USP7_MATH_1 | 285 | 289 | PF00917 | 0.538 |
DOC_USP7_MATH_1 | 338 | 342 | PF00917 | 0.746 |
DOC_USP7_MATH_1 | 422 | 426 | PF00917 | 0.615 |
DOC_USP7_MATH_1 | 472 | 476 | PF00917 | 0.626 |
DOC_USP7_UBL2_3 | 137 | 141 | PF12436 | 0.762 |
DOC_WW_Pin1_4 | 517 | 522 | PF00397 | 0.729 |
LIG_14-3-3_CanoR_1 | 304 | 310 | PF00244 | 0.735 |
LIG_14-3-3_CanoR_1 | 453 | 458 | PF00244 | 0.584 |
LIG_Actin_WH2_2 | 151 | 169 | PF00022 | 0.677 |
LIG_APCC_ABBA_1 | 532 | 537 | PF00400 | 0.508 |
LIG_BRCT_BRCA1_1 | 220 | 224 | PF00533 | 0.510 |
LIG_BRCT_BRCA1_1 | 274 | 278 | PF00533 | 0.476 |
LIG_BRCT_BRCA1_2 | 220 | 226 | PF00533 | 0.506 |
LIG_deltaCOP1_diTrp_1 | 548 | 555 | PF00928 | 0.679 |
LIG_DLG_GKlike_1 | 453 | 460 | PF00625 | 0.581 |
LIG_EH1_1 | 433 | 441 | PF00400 | 0.497 |
LIG_eIF4E_1 | 434 | 440 | PF01652 | 0.492 |
LIG_FHA_1 | 134 | 140 | PF00498 | 0.640 |
LIG_FHA_1 | 344 | 350 | PF00498 | 0.698 |
LIG_FHA_1 | 354 | 360 | PF00498 | 0.625 |
LIG_FHA_1 | 428 | 434 | PF00498 | 0.567 |
LIG_FHA_2 | 66 | 72 | PF00498 | 0.821 |
LIG_GBD_Chelix_1 | 44 | 52 | PF00786 | 0.579 |
LIG_IRF3_LxIS_1 | 480 | 487 | PF10401 | 0.651 |
LIG_LIR_Gen_1 | 264 | 272 | PF02991 | 0.534 |
LIG_LIR_Gen_1 | 308 | 313 | PF02991 | 0.645 |
LIG_LIR_Gen_1 | 320 | 330 | PF02991 | 0.626 |
LIG_LIR_Gen_1 | 372 | 381 | PF02991 | 0.627 |
LIG_LIR_Gen_1 | 478 | 489 | PF02991 | 0.521 |
LIG_LIR_Gen_1 | 533 | 539 | PF02991 | 0.598 |
LIG_LIR_Nem_3 | 264 | 268 | PF02991 | 0.535 |
LIG_LIR_Nem_3 | 323 | 327 | PF02991 | 0.596 |
LIG_LIR_Nem_3 | 372 | 376 | PF02991 | 0.582 |
LIG_LIR_Nem_3 | 478 | 484 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 533 | 538 | PF02991 | 0.590 |
LIG_NRBOX | 249 | 255 | PF00104 | 0.529 |
LIG_PCNA_yPIPBox_3 | 199 | 213 | PF02747 | 0.572 |
LIG_PCNA_yPIPBox_3 | 242 | 254 | PF02747 | 0.546 |
LIG_PCNA_yPIPBox_3 | 37 | 48 | PF02747 | 0.621 |
LIG_PTB_Apo_2 | 318 | 325 | PF02174 | 0.632 |
LIG_PTB_Apo_2 | 358 | 365 | PF02174 | 0.576 |
LIG_SH2_CRK | 389 | 393 | PF00017 | 0.529 |
LIG_SH2_GRB2like | 203 | 206 | PF00017 | 0.476 |
LIG_SH2_GRB2like | 319 | 322 | PF00017 | 0.747 |
LIG_SH2_NCK_1 | 21 | 25 | PF00017 | 0.625 |
LIG_SH2_NCK_1 | 509 | 513 | PF00017 | 0.728 |
LIG_SH2_SRC | 21 | 24 | PF00017 | 0.657 |
LIG_SH2_STAP1 | 127 | 131 | PF00017 | 0.568 |
LIG_SH2_STAP1 | 389 | 393 | PF00017 | 0.523 |
LIG_SH2_STAT3 | 302 | 305 | PF00017 | 0.725 |
LIG_SH2_STAT5 | 203 | 206 | PF00017 | 0.461 |
LIG_SH2_STAT5 | 434 | 437 | PF00017 | 0.561 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.633 |
LIG_SH2_STAT5 | 519 | 522 | PF00017 | 0.706 |
LIG_SH2_STAT5 | 529 | 532 | PF00017 | 0.556 |
LIG_SH3_3 | 330 | 336 | PF00018 | 0.743 |
LIG_SH3_4 | 137 | 144 | PF00018 | 0.688 |
LIG_SH3_4 | 234 | 241 | PF00018 | 0.726 |
LIG_TRAF2_1 | 381 | 384 | PF00917 | 0.632 |
LIG_TRAF2_1 | 410 | 413 | PF00917 | 0.630 |
LIG_TRFH_1 | 324 | 328 | PF08558 | 0.692 |
LIG_TRFH_1 | 364 | 368 | PF08558 | 0.590 |
LIG_TYR_ITIM | 387 | 392 | PF00017 | 0.541 |
LIG_UBA3_1 | 131 | 137 | PF00899 | 0.653 |
LIG_UBA3_1 | 363 | 369 | PF00899 | 0.636 |
LIG_UBA3_1 | 500 | 507 | PF00899 | 0.649 |
MOD_CDK_SPxK_1 | 517 | 523 | PF00069 | 0.724 |
MOD_CK1_1 | 144 | 150 | PF00069 | 0.766 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.542 |
MOD_CK1_1 | 329 | 335 | PF00069 | 0.721 |
MOD_CK1_1 | 456 | 462 | PF00069 | 0.587 |
MOD_CK2_1 | 158 | 164 | PF00069 | 0.572 |
MOD_CK2_1 | 208 | 214 | PF00069 | 0.578 |
MOD_CK2_1 | 317 | 323 | PF00069 | 0.734 |
MOD_CK2_1 | 338 | 344 | PF00069 | 0.758 |
MOD_CK2_1 | 372 | 378 | PF00069 | 0.553 |
MOD_CK2_1 | 472 | 478 | PF00069 | 0.607 |
MOD_CK2_1 | 496 | 502 | PF00069 | 0.552 |
MOD_GlcNHglycan | 182 | 186 | PF01048 | 0.625 |
MOD_GlcNHglycan | 274 | 277 | PF01048 | 0.597 |
MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.661 |
MOD_GlcNHglycan | 314 | 317 | PF01048 | 0.659 |
MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.661 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.708 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.519 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.553 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.519 |
MOD_GSK3_1 | 154 | 161 | PF00069 | 0.567 |
MOD_GSK3_1 | 268 | 275 | PF00069 | 0.587 |
MOD_GSK3_1 | 339 | 346 | PF00069 | 0.707 |
MOD_GSK3_1 | 455 | 462 | PF00069 | 0.569 |
MOD_GSK3_1 | 484 | 491 | PF00069 | 0.569 |
MOD_GSK3_1 | 496 | 503 | PF00069 | 0.461 |
MOD_GSK3_1 | 513 | 520 | PF00069 | 0.690 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.707 |
MOD_N-GLC_1 | 482 | 487 | PF02516 | 0.585 |
MOD_NEK2_1 | 125 | 130 | PF00069 | 0.496 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.527 |
MOD_NEK2_1 | 154 | 159 | PF00069 | 0.661 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.542 |
MOD_NEK2_1 | 272 | 277 | PF00069 | 0.553 |
MOD_NEK2_1 | 312 | 317 | PF00069 | 0.687 |
MOD_NEK2_1 | 397 | 402 | PF00069 | 0.600 |
MOD_NEK2_1 | 427 | 432 | PF00069 | 0.602 |
MOD_NEK2_1 | 484 | 489 | PF00069 | 0.520 |
MOD_NEK2_1 | 490 | 495 | PF00069 | 0.572 |
MOD_NEK2_1 | 551 | 556 | PF00069 | 0.664 |
MOD_OFUCOSY | 282 | 289 | PF10250 | 0.611 |
MOD_PKA_1 | 140 | 146 | PF00069 | 0.742 |
MOD_PKA_1 | 453 | 459 | PF00069 | 0.586 |
MOD_PKA_2 | 144 | 150 | PF00069 | 0.684 |
MOD_PKA_2 | 453 | 459 | PF00069 | 0.588 |
MOD_PKA_2 | 522 | 528 | PF00069 | 0.676 |
MOD_PKA_2 | 61 | 67 | PF00069 | 0.727 |
MOD_Plk_1 | 482 | 488 | PF00069 | 0.607 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.550 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.654 |
MOD_Plk_4 | 372 | 378 | PF00069 | 0.593 |
MOD_Plk_4 | 427 | 433 | PF00069 | 0.547 |
MOD_Plk_4 | 456 | 462 | PF00069 | 0.600 |
MOD_Plk_4 | 496 | 502 | PF00069 | 0.533 |
MOD_Plk_4 | 522 | 528 | PF00069 | 0.663 |
MOD_ProDKin_1 | 517 | 523 | PF00069 | 0.724 |
MOD_SUMO_for_1 | 225 | 228 | PF00179 | 0.498 |
MOD_SUMO_rev_2 | 211 | 217 | PF00179 | 0.624 |
MOD_SUMO_rev_2 | 34 | 38 | PF00179 | 0.629 |
TRG_DiLeu_BaEn_1 | 105 | 110 | PF01217 | 0.600 |
TRG_DiLeu_BaEn_1 | 171 | 176 | PF01217 | 0.603 |
TRG_ENDOCYTIC_2 | 319 | 322 | PF00928 | 0.776 |
TRG_ENDOCYTIC_2 | 389 | 392 | PF00928 | 0.524 |
TRG_ENDOCYTIC_2 | 529 | 532 | PF00928 | 0.494 |
TRG_ER_diArg_1 | 110 | 112 | PF00400 | 0.619 |
TRG_ER_diArg_1 | 452 | 454 | PF00400 | 0.573 |
TRG_ER_diArg_1 | 474 | 477 | PF00400 | 0.662 |
TRG_NLS_MonoExtC_3 | 294 | 299 | PF00514 | 0.692 |
TRG_Pf-PMV_PEXEL_1 | 111 | 115 | PF00026 | 0.615 |
TRG_Pf-PMV_PEXEL_1 | 46 | 51 | PF00026 | 0.638 |
TRG_Pf-PMV_PEXEL_1 | 506 | 510 | PF00026 | 0.690 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8Z8 | Leptomonas seymouri | 79% | 100% |
A0A0S4ILH8 | Bodo saltans | 28% | 100% |
A0A1X0NLF6 | Trypanosomatidae | 48% | 99% |
A0A422NJ69 | Trypanosoma rangeli | 48% | 99% |
A4HQC9 | Leishmania braziliensis | 90% | 100% |
A4IE22 | Leishmania infantum | 100% | 100% |
D0A3X0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9AU45 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 100% |
Q4Q0F0 | Leishmania major | 97% | 100% |
V5BT61 | Trypanosoma cruzi | 48% | 99% |